In May 2020 a group of experts came together, at speed, to form the UK’s Vaccine Task Force. Born in the teeth of a crisis, its efforts were responsible for allowing Britain to be among the first countries in the world to roll out vaccines against Covid-19.

But as memories of the pandemic fade, the urgency it brought to its work has subsided as well. In this edition of Analysis, Sandra Kanthal asks what lessons have been learned from the success of the Vaccine Task Force and if we should be prepared to allocate the time, energy and expense required to be permanently prepared for the next global health emergency.

Presenter: Sandra Kanthal